<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Benlarbi M</submitter><funding>NIA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>BioRender</funding><funding>CIHR</funding><pagination>763-774</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10938206</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>229(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Chronic inflammation persists in some people living with human immunodeficiency virus (HIV) during antiretroviral therapy and is associated with premature aging. The glycoprotein 120 (gp120) subunit of HIV-1 envelope sheds and can be detected in plasma, showing immunomodulatory properties even in the absence of detectable viremia. We evaluated whether plasma soluble gp120 (sgp120) and a family of gp120-specific anti-cluster A antibodies, linked to CD4 depletion in vitro, contribute to chronic inflammation, immune dysfunction, and subclinical cardiovascular disease in participants of the Canadian HIV and Aging Cohort Study with undetectable viremia.&lt;h4>Methods&lt;/h4>Cross-sectional assessment of sgp120 and anti-cluster A antibodies was performed in 386 individuals from the </pubmed_abstract><journal>The Journal of infectious diseases</journal><pubmed_title>Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.</pubmed_title><pmcid>PMC10938206</pmcid><funding_grant_id>UM1 AI164562</funding_grant_id><funding_grant_id>R01 AI129769</funding_grant_id><funding_grant_id>R01 AI148379</funding_grant_id><funding_grant_id>UM1 AI164560</funding_grant_id><funding_grant_id>R01 AI150322</funding_grant_id><funding_grant_id>R01 AI174908</funding_grant_id><funding_grant_id>R01 AI176531</funding_grant_id><funding_grant_id>R01 AG054324</funding_grant_id><funding_grant_id>R01 AI116274</funding_grant_id><pubmed_authors>Maldarelli F</pubmed_authors><pubmed_authors>Kaufmann DE</pubmed_authors><pubmed_authors>Tolbert WD</pubmed_authors><pubmed_authors>Clark A</pubmed_authors><pubmed_authors>Sylla M</pubmed_authors><pubmed_authors>Baril JG</pubmed_authors><pubmed_authors>Benlarbi M</pubmed_authors><pubmed_authors>Gendron-Lepage G</pubmed_authors><pubmed_authors>Finzi A</pubmed_authors><pubmed_authors>Richard J</pubmed_authors><pubmed_authors>Duerr R</pubmed_authors><pubmed_authors>Durand M</pubmed_authors><pubmed_authors>Verly MM</pubmed_authors><pubmed_authors>Fromentin R</pubmed_authors><pubmed_authors>Turcotte I</pubmed_authors><pubmed_authors>Tremblay C</pubmed_authors><pubmed_authors>Pazgier M</pubmed_authors><pubmed_authors>Chomont N</pubmed_authors><pubmed_authors>Chartrand-Lefebvre C</pubmed_authors><pubmed_authors>Begin P</pubmed_authors><pubmed_authors>Trottier S</pubmed_authors><pubmed_authors>Prevost J</pubmed_authors><pubmed_authors>Messier-Peet M</pubmed_authors><pubmed_authors>Mothes W</pubmed_authors><pubmed_authors>Bourassa C</pubmed_authors><pubmed_authors>Trottier B</pubmed_authors><pubmed_authors>Guertin C</pubmed_authors><pubmed_authors>El-Far M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.</name><description>&lt;h4>Background&lt;/h4>Chronic inflammation persists in some people living with human immunodeficiency virus (HIV) during antiretroviral therapy and is associated with premature aging. The glycoprotein 120 (gp120) subunit of HIV-1 envelope sheds and can be detected in plasma, showing immunomodulatory properties even in the absence of detectable viremia. We evaluated whether plasma soluble gp120 (sgp120) and a family of gp120-specific anti-cluster A antibodies, linked to CD4 depletion in vitro, contribute to chronic inflammation, immune dysfunction, and subclinical cardiovascular disease in participants of the Canadian HIV and Aging Cohort Study with undetectable viremia.&lt;h4>Methods&lt;/h4>Cross-sectional assessment of sgp120 and anti-cluster A antibodies was performed in 386 individuals from the </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-24T03:09:37.858Z</modification><creation>2026-06-24T03:06:26.637Z</creation></dates><accession>S-EPMC10938206</accession><cross_references><pubmed>38035854</pubmed><doi>10.1093/infdis/jiad503</doi></cross_references></HashMap>